PERLETTI, GIANPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 17.052
EU - Europa 8.833
AS - Asia 6.541
SA - Sud America 867
AF - Africa 349
Continente sconosciuto - Info sul continente non disponibili 245
OC - Oceania 165
Totale 34.052
Nazione #
US - Stati Uniti d'America 16.695
IT - Italia 4.326
SG - Singapore 1.852
UA - Ucraina 1.253
CN - Cina 1.238
VN - Vietnam 804
TR - Turchia 687
BR - Brasile 678
SE - Svezia 667
HK - Hong Kong 645
GB - Regno Unito 495
IE - Irlanda 388
DE - Germania 357
FI - Finlandia 346
FR - Francia 312
IN - India 272
RU - Federazione Russa 210
CA - Canada 208
AU - Australia 134
BD - Bangladesh 122
ID - Indonesia 115
IQ - Iraq 110
PK - Pakistan 100
IR - Iran 95
NG - Nigeria 95
MX - Messico 92
JP - Giappone 73
EG - Egitto 71
ES - Italia 71
KR - Corea 66
PL - Polonia 59
NL - Olanda 58
AR - Argentina 57
ZA - Sudafrica 51
TH - Thailandia 49
TW - Taiwan 49
BE - Belgio 48
MY - Malesia 47
GR - Grecia 42
PH - Filippine 41
NP - Nepal 30
EC - Ecuador 29
NZ - Nuova Zelanda 28
PE - Perù 26
CO - Colombia 24
DZ - Algeria 23
CZ - Repubblica Ceca 22
JO - Giordania 22
AT - Austria 21
BG - Bulgaria 20
KE - Kenya 20
RS - Serbia 20
UG - Uganda 20
GH - Ghana 19
PT - Portogallo 17
RO - Romania 17
SA - Arabia Saudita 17
MA - Marocco 16
UZ - Uzbekistan 16
IL - Israele 15
VE - Venezuela 15
CH - Svizzera 14
CL - Cile 14
EU - Europa 13
AE - Emirati Arabi Uniti 11
LT - Lituania 11
AL - Albania 10
QA - Qatar 10
TN - Tunisia 10
YE - Yemen 10
UY - Uruguay 9
HU - Ungheria 8
JM - Giamaica 8
MD - Moldavia 8
SK - Slovacchia (Repubblica Slovacca) 8
BO - Bolivia 7
CR - Costa Rica 7
DK - Danimarca 7
ET - Etiopia 7
AZ - Azerbaigian 6
PY - Paraguay 6
SN - Senegal 6
CU - Cuba 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LB - Libano 5
NI - Nicaragua 5
PS - Palestinian Territory 5
GT - Guatemala 4
LK - Sri Lanka 4
LV - Lettonia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
FJ - Figi 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
OM - Oman 3
Totale 33.776
Città #
Milan 2.841
Fairfield 1.592
Ashburn 1.342
San Jose 1.077
Singapore 1.068
Woodbridge 1.033
Jacksonville 956
Chandler 821
Houston 804
Seattle 691
Wilmington 617
Hong Kong 596
Cambridge 566
Ann Arbor 493
Dublin 374
Council Bluffs 370
Dallas 368
Princeton 368
Dearborn 343
Nyköping 337
Izmir 300
Beijing 298
Rome 265
The Dalles 228
Boardman 226
Chicago 225
Dong Ket 195
Lauterbourg 181
New York 171
Ho Chi Minh City 168
Como 167
Los Angeles 165
Santa Clara 129
San Mateo 122
San Diego 117
Hanoi 108
London 82
Ogden 77
Orem 71
Atlanta 63
Tokyo 57
San Francisco 56
Guangzhou 54
Helsinki 54
Montreal 54
São Paulo 54
Abuja 49
Denver 45
Shanghai 44
Brooklyn 40
Verona 40
Chennai 39
Jakarta 39
Munich 39
Toronto 39
Warsaw 39
Mexico City 37
Sydney 37
Bangkok 36
Brisbane 36
Washington 36
Manchester 35
Nanjing 35
Phoenix 35
Hefei 34
Kocaeli 33
Kunming 31
Cairo 30
Sulaymaniyah 29
Lahore 27
Boston 25
Baghdad 24
Mumbai 24
Pioltello 24
Rio de Janeiro 24
Stockholm 24
Moscow 23
Johannesburg 22
Memphis 22
Portland 22
Shenzhen 22
Amman 21
Lagos 21
Rozzano 21
Tianjin 21
Brussels 20
Nuremberg 20
Frankfurt am Main 19
Hangzhou 19
Las Vegas 19
Madrid 19
Pune 19
Athens 18
Haiphong 18
Kampala 18
Kuala Lumpur 18
Ankara 17
Brno 17
Cleveland 17
Manila 17
Totale 21.843
Nome #
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials 1.035
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer 1.007
Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes 828
Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials 695
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials 561
Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis 353
Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis 313
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 261
Risk of urinary stone formation associated to proton pump inhibitors: a systematic review and metanalysis 251
The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women 250
Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials 248
Serenoa repens and Pygeum Africanum in the treatment of BPH 248
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study 242
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up 237
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOFORMS IN THE EARLY STAGES OF DIETHYLNITROSAMINE-INDUCED RAT HEPATOCARCINOGENESIS 234
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay 234
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. 232
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 227
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene. 226
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients 225
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity 224
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. 219
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 215
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin? 215
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil 211
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. 210
Anti-infective treatment of bacterial urinary tract infections. 209
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. 208
Chronic bacterial prostatitis: enterococcal disease? 208
Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation 208
A new approach to the direct detection of free radicals in the intact myocardium. 207
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. 204
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis 203
Antimicrobials in urogenital infections. 202
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. 199
Computer-assisted quantitative assessment of prostatic calcifications in patients with chronic prostatitis 199
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 197
Finafloxacin for the treatment of urinary tract infections 197
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. 197
p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells 196
Azithromycin: mechanisms of action and their relevance for clinical applications. 196
Antimicrobial therapy for chronic bacterial prostatitis. 195
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. 193
Sexuality, Sexual Orientation and Chronic Prostatitis 193
α-blockers and antibiotics, alone or in combination, improve symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. 192
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). 191
Prevalence of erectile and ejaculatory dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome 191
National institute of health chronic prostatitis symptom index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients 190
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 189
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis 188
FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer 188
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review) 187
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. 185
Herbal medicines for urinary stone treatment. A systematic review 185
Structure and function of the extraembryonic membrane persisting around the larvae of the parasitoid Toxoneuron nigriceps. 183
Prevention and modulation of aminoglycoside ototoxicity (Review) 183
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting 183
INTERACTION OF CU(II) AND CU(II)-ANTHRACYCLINE COMPLEXES WITH PROTEIN-KINASE-C - SPECTROMAGNETIC ASSESSMENT OF THE INHIBITORY EFFECT 182
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate 182
Epidemiology of urolithiasis in Europe and Latin America: A systematic review 177
Leech responses to tissue transplantation 177
Lithogenic Potential of Ureaplasma in Chronic Prostatitis 177
Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity. 176
Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer 175
Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study 175
Collagen organization in leech wound healing. 174
DIFFERENTIAL PHORBOL ESTER GROWTH MODULATION AND PROTEIN-KINASE-C ISOENZYME EXPRESSION IN RAT HEPATOMA-CELLS VS NON NEOPLASTIC RAT HEPATOCYTES 174
PROTECTIVE EFFECTS OF SPIN-TRAPPING AGENTS ON ADRIAMYCIN-INDUCED CARDIOTOXICITY IN ISOLATED RAT ATRIA 171
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model 170
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. 170
Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth 169
Emerging drugs for bacterial urinary tract infections. 169
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 167
PROTEIN-KINASE-C ISOZYMES DURING LIVER-REGENERATION 166
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation. 166
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients 166
PROTEIN-KINASE-C ISOZYME PATTERN IN LIVER HYPERPLASIA 165
THE INHIBITORY EFFECT OF CU(II) ON PROTEIN-KINASE-C IS ENHANCED BY ANTHRACYCLINES - AN ESR STUDY 164
Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity. 164
Risk factors analysis in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from Finland, Germany, Italy and Switzerland: Results of a multinational observational study 164
Effect of doxorubicin on calcium receptors of myocardial cells. 163
Re: Samplaski et al.: Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. (Urology 2011;78:653-658). 163
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study 163
Early suppression of immune response in Heliothis virescens larvae by the endophagous parasitoid Toxoneuron nigriceps 162
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome 161
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. 160
PARTIAL-PURIFICATION OF PROTEIN-KINASE-C ISOENZYMES FROM RAT-LIVER 160
VEGF stimulates angiogenesis in Hirudo medicinalis. 160
Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study 160
Wound repair in Hirudo medicinalis: phases and response modulation 159
Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments 159
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOENZYMES IN INTRINSICALLY RESISTANT CLONED LINES OF LOVO CELLS - REVERSAL OF RESISTANCE BY KINASE INHIBITOR 1-(5-ISOQINOLINYLSULFONYL) 2-METHYLPIPERAZINE 158
Multidisciplinary approach to prostatitis 158
Distinctive cellular roles for novel protein kinase C isoenzymes 157
Anti-cancer potential of edible/medicinal mushrooms in breast cancer 156
Current knowledge of the potential links between inflammation and prostate cancer 156
Hematopoietic cell formation in leech wound healing. 156
THE ACTIVITY OF A BETA-SUBTYPE OF PROTEIN-KINASE-C PURIFIED FROM NUCLEI OF HUMAN NEUTROPHILS IS ENHANCED BY TREATMENT WITH PHORBOL 12-MYRISTATE 13-ACETATE 155
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV 154
Leeches: Immune response, angiogenesis and biomedical applications 154
Totale 22.361
Categoria #
all - tutte 127.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.780 0 191 128 173 31 99 82 152 258 240 154 272
2022/20232.265 262 122 235 199 170 488 3 284 285 79 75 63
2023/20244.839 675 731 765 812 905 256 60 109 148 118 117 143
2024/20254.058 136 145 605 134 184 221 176 303 417 422 404 911
2025/20268.399 608 494 440 1.054 749 468 1.580 558 829 606 444 569
2026/20272.001 1.447 554 0 0 0 0 0 0 0 0 0 0
Totale 34.052